News Author: HT Staff Publish date: May 4, 2018
More than 2000 genes are “essential” for the malaria parasite Plasmodium falciparum, according to research published in Science.
Researchers identi...
News Author: HT Staff Publish date: May 4, 2018
New research has revealed a link between earthquake evacuation and venous thromboembolism (VTE).
The study showed that people who spent the night i...
News Author: HT Staff Publish date: May 4, 2018
Having type O blood is associated with high death rates in severe trauma patients, according to a study published in Critical Care.
Researchers fou...
News Author: HT Staff Publish date: May 3, 2018
Cell therapy could produce lasting effects in hemophilia B, according to a group of researchers.
They genetically modified induced pluripotent cell...
News Author: HT Staff Publish date: May 3, 2018
The US Food and Drug Administration (FDA) has issued a complete response letter (CRL) saying the agency cannot approve Sandoz’s proposed biosimilar...
News Author: HT Staff Publish date: May 3, 2018
An investigational JAK1/2 inhibitor can fight graft-versus-host disease (GVHD), according to preclinical research published in Leukemia.
The inhibi...
News Author: HT Staff Publish date: May 2, 2018
The US Food and Drug Administration (FDA) has approved tisagenlecleucel (Kymriah®) for its second indication. The chimeric antigen receptor (CAR) T...
News Author: HT Staff Publish date: May 2, 2018
Researchers say they’ve discovered why multiple myeloma (MM) patients may experience chemotherapy-induced peripheral neuropathy (CIPN) when treated wi...
News Author: HT Staff Publish date: May 2, 2018
Preclinical research suggests PI3K inhibitors could treat hereditary hemorrhagic telangiectasia (HHT).
Experiments in mice and patient samples reve...
News Author: HT Staff Publish date: May 1, 2018
Researchers may have discovered why some patients with advanced chronic lymphocytic leukemia (CLL) don’t respond to chimeric antigen receptor (CAR) T-...
News Author: HT Staff Publish date: May 1, 2018
New research has revealed 5 genetic subtypes of diffuse large B-cell lymphoma (DLBCL). Researchers identified a group of low-risk activated B-cell ...
News Author: HT Staff Publish date: May 1, 2018
Fostamatinib has produced “clinically meaningful” responses in adults with persistent or chronic immune thrombocytopenia (ITP), according to researche...
News Author: HT Staff Publish date: April 30, 2018
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended changes to the marketing authorization for dasat...
News Author: HT Staff Publish date: April 29, 2018
The US Food and Drug Administration (FDA) has granted a second breakthrough therapy designation to OMS721.
OMS721 is a monoclonal antibody targetin...
News Author: HT Staff Publish date: April 28, 2018
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion of Carmustine Obvius, a generic v...
